NORTHERN TRUST CORP - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 46 filers reported holding VYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$13,421
-32.9%
89,4720.0%0.00%
Q3 2022$20,000
-42.9%
89,4720.0%0.00%
Q2 2022$35,000
-39.7%
89,4720.0%0.00%
Q1 2022$58,000
-36.3%
89,472
-0.0%
0.00%
Q4 2021$91,000
-57.3%
89,477
-41.7%
0.00%
Q3 2021$213,000
-38.4%
153,553
+55.9%
0.00%
Q2 2021$346,000
-87.1%
98,524
-74.9%
0.00%
-100.0%
Q1 2021$2,692,000393,2720.00%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,038,0001.04%
DELTEC ASSET MANAGEMENT LLC 30,000$12,0000.00%
Tekla Capital Management LLC 135,395$53,0000.00%
Virtu Financial LLC 64,838$25,0000.00%
TWO SIGMA SECURITIES, LLC 127,844$50,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$24,0000.00%
Beacon Pointe Advisors, LLC 75,000$28,0000.00%
Cetera Advisor Networks LLC 115,000$45,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$4,0000.00%
Russell Investments Group, Ltd. 3,375$1,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders